More on TRUFF
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.02 |
|
|||
| Open | $0.02 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $0.02 | ||||
| Day Low | $0.02 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 232,421 | ||||
- Red Light Holland Reports Fiscal 2026 Audited Year-End Results and Provides Update on Rhelion Life Sciences
- Red Light Holland Announces Corporate Rebrand to Rhelion Life Sciences Corp
- Red Light Holland Announces New Filament Health PEX010 European Research Shipment
- Red Light Holland Announces Filament Health's Largest-Ever Manufacturing Run of PEX010, the Standardized and Patented Natural Psilocybin Drug Candidate Trusted Across 80+ Studies Globally, Now Offerin
- Filament Health to supply psilocybin drug for veterans PTSD study
- Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Military Veterans PTSD Study at ARQ National Psychotrauma Centre
- Red Light Holland reports preclinical coca extract results for post-GLP-1 weight management
- Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filam
- Red Light Holland subsidiary signs psilocybin supply deal with Paris hospital
- Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Study at GHU Paris Psychiatrie & Neurosciences in France
Entities mentioned with TRUFF
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Bitcoin | View Related Stories »
- Twitter | View Related Stories »
- Show More...
